Intelligent Bio Solutions

Intelligent Bio Solutions (formerly GBS Inc.) is a New York-based medical technology company developing intelligent, rapid, non-invasive diagnostic screening built on fingerprint sweat analysis. Its Intelligent Fingerprinting Drug Screening System detects drug use from fingerprint sweat in minutes without sample handling, and the company is advancing an FDA 510(k) submission for U.S. market entry, anchored by codeine-detection studies including an Interference Study and a multi-site Method Comparison Study completed in August 2026. The company also develops a biosensor platform and serves workplace, clinical, and corrections screening markets across the U.S., U.K., and Asia Pacific.